Endothelial Cell Contributions to COVID-19

Area of Science:

• Virology
• Pathology
• Molecular Biology

Background:

• The clinical, histological, and molecular features of SARS-CoV-2 remain incompletely understood.
• COVID-19 presents with unusual clinical manifestations compared to other coronaviruses.
• Emerging evidence suggests SARS-CoV-2 infects endothelial cells, potentially explaining significant clinical pathology and increased mortality linked to vascular dysfunction.

Purpose of the Study:

• To elucidate the molecular and cellular mechanisms by which SARS-CoV-2 causes endothelial cell pathology.
• To connect endothelial cell dysfunction to the broader clinical presentation of COVID-19.
• To review current knowledge on inflammatory pathways, endothelial cell-derived exosomes, and transdifferentiation in SARS-CoV-2 infection.

Main Methods:

• Literature review focusing on molecular and cellular pathology of SARS-CoV-2 in endothelial cells.
• Examination of canonical inflammatory pathways involved in COVID-19.
• Assessment of SARS-CoV-2's impact on endothelial cell-derived exosomes and transdifferentiation.

Main Results:

• SARS-CoV-2 infection of endothelial cells is a key factor in COVID-19 pathology.
• Endothelial cell dysfunction is strongly associated with increased COVID-19 mortality.
• The virus alters inflammatory responses and endothelial cell behavior, including exosome release and transdifferentiation.

Conclusions:

• Endothelial cell pathology is central to understanding COVID-19's clinical manifestations and severity.
• Targeting endothelial function presents a promising therapeutic strategy for COVID-19.
• Further research into SARS-CoV-2's molecular interactions with endothelial cells is crucial for developing effective treatments.